{"id":521016,"date":"2021-08-02T06:48:10","date_gmt":"2021-08-02T10:48:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\/"},"modified":"2021-08-02T06:48:10","modified_gmt":"2021-08-02T10:48:10","slug":"reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\/","title":{"rendered":"Reata Pharmaceuticals, Inc. to Report Second Quarter 2021 Financial Results and Provide an Update on Development Programs on August 9, 2021"},"content":{"rendered":"

<\/p>\n

Reata Pharmaceuticals, Inc. to Report Second Quarter 2021 Financial Results and Provide an Update on Development Programs on August 9, 2021<\/b><\/p>\n

PLANO, Texas–(BUSINESS WIRE<\/a>)–Reata Pharmaceuticals, Inc.<\/a> (Nasdaq: RETA) (\u201cReata\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company, today announced that it will report financial results and provide an update on recent progress on its development programs after the market closes on August 9, 2021.\n<\/p>\n

\nReata\u2019s management will host a conference call on August 9, 2021, at 4:30 pm ET. The conference call will be accessible by dialing (866) 270-1533 (toll-free domestic) or (412) 317-0797 (international) using the access code: 10157197. The webcast link is https:\/\/event.on24.com\/wcc\/r\/3196578\/57A5A4A99C3D3BA0F2D6A7D9D86B06B7<\/a>.\n<\/p>\n

\nSecond quarter financial results to be discussed during the call will be included in an earnings press release that will be available on the company\u2019s website shortly before the call at https:\/\/www.reatapharma.com\/investors\/<\/a> and will be available for 12 months after the call. The audio recording and webcast will be accessible for at least 90 days after the event at https:\/\/www.reatapharma.com\/investors\/<\/a>.\n<\/p>\n

About Reata Pharmaceuticals, Inc.<\/b><\/p>\n

\nReata is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways that regulate cellular metabolism, inflammation, and the cellular response to injury. Reata\u2019s two most advanced clinical candidates, bardoxolone methyl (\u201cbardoxolone\u201d) and omaveloxolone, target the important transcription factor Nrf2 that promotes the resolution of inflammation by restoring mitochondrial function, reducing oxidative stress, and inhibiting pro-inflammatory signaling. We possess exclusive, worldwide rights to develop, manufacture, and commercialize bardoxolone, omaveloxolone, and our next-generation Nrf2 activators, excluding certain Asian markets for bardoxolone in certain indications, which are licensed to Kyowa Kirin Co., Ltd. Bardoxolone and omaveloxolone are investigational drugs, and their safety and efficacy have not been established by any agency.<\/b><\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210802005132\/en\/<\/a><\/span><\/p>\n

\nReata Pharmaceuticals, Inc.
\n
(972) 865-2219
\n
https:\/\/www.reatapharma.com\/<\/a><\/p>\n

Investor Relations & Media:
\n<\/b>
Manmeet Soni
\n
Andres Lorente
\n
ir@reatapharma.com
\n<\/a>
media@reatapharma.com
\n<\/a>
https:\/\/www.reatapharma.com\/contact-us\/<\/a><\/p>\n

KEYWORDS:<\/b> United States North America Texas<\/p>\n

INDUSTRY KEYWORDS:<\/b> Health Other Science Research Pharmaceutical Science Biotechnology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Reata Pharmaceuticals, Inc. to Report Second Quarter 2021 Financial Results and Provide an Update on Development Programs on August 9, 2021 PLANO, Texas–(BUSINESS WIRE)–Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (\u201cReata\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company, today announced that it will report financial results and provide an update on recent progress on its development programs after the market closes on August 9, 2021. Reata\u2019s management will host a conference call on August 9, 2021, at 4:30 pm ET. The conference call will be accessible by dialing (866) 270-1533 (toll-free domestic) or (412) 317-0797 (international) using the access code: 10157197. The webcast link is https:\/\/event.on24.com\/wcc\/r\/3196578\/57A5A4A99C3D3BA0F2D6A7D9D86B06B7. Second quarter financial results to be discussed during the call will be included in an earnings … <\/p>\n

Continue reading “Reata Pharmaceuticals, Inc. to Report Second Quarter 2021 Financial Results and Provide an Update on Development Programs on August 9, 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-521016","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nReata Pharmaceuticals, Inc. to Report Second Quarter 2021 Financial Results and Provide an Update on Development Programs on August 9, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Reata Pharmaceuticals, Inc. to Report Second Quarter 2021 Financial Results and Provide an Update on Development Programs on August 9, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Reata Pharmaceuticals, Inc. to Report Second Quarter 2021 Financial Results and Provide an Update on Development Programs on August 9, 2021 PLANO, Texas–(BUSINESS WIRE)–Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (\u201cReata\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company, today announced that it will report financial results and provide an update on recent progress on its development programs after the market closes on August 9, 2021. Reata\u2019s management will host a conference call on August 9, 2021, at 4:30 pm ET. The conference call will be accessible by dialing (866) 270-1533 (toll-free domestic) or (412) 317-0797 (international) using the access code: 10157197. The webcast link is https:\/\/event.on24.com\/wcc\/r\/3196578\/57A5A4A99C3D3BA0F2D6A7D9D86B06B7. Second quarter financial results to be discussed during the call will be included in an earnings … Continue reading "Reata Pharmaceuticals, Inc. to Report Second Quarter 2021 Financial Results and Provide an Update on Development Programs on August 9, 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-02T10:48:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210802005132r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Reata Pharmaceuticals, Inc. to Report Second Quarter 2021 Financial Results and Provide an Update on Development Programs on August 9, 2021\",\"datePublished\":\"2021-08-02T10:48:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\\\/\"},\"wordCount\":379,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210802005132r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\\\/\",\"name\":\"Reata Pharmaceuticals, Inc. to Report Second Quarter 2021 Financial Results and Provide an Update on Development Programs on August 9, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210802005132r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-08-02T10:48:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210802005132r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210802005132r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Reata Pharmaceuticals, Inc. to Report Second Quarter 2021 Financial Results and Provide an Update on Development Programs on August 9, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Reata Pharmaceuticals, Inc. to Report Second Quarter 2021 Financial Results and Provide an Update on Development Programs on August 9, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\/","og_locale":"en_US","og_type":"article","og_title":"Reata Pharmaceuticals, Inc. to Report Second Quarter 2021 Financial Results and Provide an Update on Development Programs on August 9, 2021 - Market Newsdesk","og_description":"Reata Pharmaceuticals, Inc. to Report Second Quarter 2021 Financial Results and Provide an Update on Development Programs on August 9, 2021 PLANO, Texas–(BUSINESS WIRE)–Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (\u201cReata\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company, today announced that it will report financial results and provide an update on recent progress on its development programs after the market closes on August 9, 2021. Reata\u2019s management will host a conference call on August 9, 2021, at 4:30 pm ET. The conference call will be accessible by dialing (866) 270-1533 (toll-free domestic) or (412) 317-0797 (international) using the access code: 10157197. The webcast link is https:\/\/event.on24.com\/wcc\/r\/3196578\/57A5A4A99C3D3BA0F2D6A7D9D86B06B7. Second quarter financial results to be discussed during the call will be included in an earnings … Continue reading \"Reata Pharmaceuticals, Inc. to Report Second Quarter 2021 Financial Results and Provide an Update on Development Programs on August 9, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-02T10:48:10+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210802005132r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Reata Pharmaceuticals, Inc. to Report Second Quarter 2021 Financial Results and Provide an Update on Development Programs on August 9, 2021","datePublished":"2021-08-02T10:48:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\/"},"wordCount":379,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210802005132r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\/","name":"Reata Pharmaceuticals, Inc. to Report Second Quarter 2021 Financial Results and Provide an Update on Development Programs on August 9, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210802005132r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-08-02T10:48:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210802005132r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210802005132r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reata-pharmaceuticals-inc-to-report-second-quarter-2021-financial-results-and-provide-an-update-on-development-programs-on-august-9-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Reata Pharmaceuticals, Inc. to Report Second Quarter 2021 Financial Results and Provide an Update on Development Programs on August 9, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/521016","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=521016"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/521016\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=521016"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=521016"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=521016"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}